Innovent Biologics Competitors and Similar CompaniesClear all

Innovent Biologics's competitors and similar companies include Bausch Health Americas, Octapharma and Tianjin Tianyao Pharmaceutical.

	Innovent Biologics Innovent Biologics is a biopharmaceutical company that develops and manufactures drugs.	Bausch Health Americas Bausch Health Americas (BHA) is a pharmaceutical preparation manufacturing company.	Octapharma Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines.	Tianjin Tianyao Pharmaceutical Tianjin Tianyao Pharmaceutical (天津天药药业股份有限公司) is a company that manufactures injection products.
Founding Date	Founding Date 2011	Founding Date 1994	Founding Date 1983	Founding Date 1939
Type	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations Suzhou, CN HQ	Locations Bridgewater, US HQ Laval, CA Steinbach, CA Envigado, CO La Estrella, CO Medellín, CO Ciudad De México, MX see more	Locations Lachen, CH HQ Pyrmont, AU Wien, AT Baku, AZ Minsk, BY Anderlecht, BE see more	Locations CN HQ
Employees	Employees 5,659	Employees 4,044	Employees 12,000	Employees 2,884
Financial
Revenue (est.)	Revenue (est.) ¥13b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €2.5b (FY, 2021)	Revenue (est.) ¥2.9b (FY, 2025)
Cost of goods	Cost of goods ¥1.1b (FY, 2025)	Cost of goods N/A	Cost of goods €1.7b (FY, 2021)	Cost of goods ¥1.7b (FY, 2025)
Gross profit	Gross profit ¥12b (FY, 2025)	Gross profit N/A	Gross profit €808.2m (FY, 2021)	Gross profit ¥1.2b (FY, 2025)
Net income	Net income ¥813.6m (FY, 2025)	Net income N/A	Net income €438.3m (FY, 2021)	Net income ¥122.1m (FY, 2025)